Actavis to Pay $84 Million

Actavis Group has agreed to pay $84 million to resolve allegations that it reported inflated prices in order to increase the amount that Medicaid and other healthcare companies would pay for its prescription drugs.  The settlement comes after a Texas jury ruled against Actavis for $170.3 million last February.  As part of the settlement, both…

Read More

Documents Released in BNY Mellon Case

Many confidential documents in the fraud case against BNY Mellon have been released to the public.  The suit alleges that BNY Mellon defrauded customers of millions of dollars by giving those trading in a foreign currency exchange the worst exchange rate for a day while giving customers the understanding that they were receiving the best…

Read More

Second Judge Rejects an SEC Settlement

After Judge Rakoff’s rejection of the SEC’s proposed settlement with Citigroup, a Milwaukee federal judge has questioned another SEC settlement.  U.S. District Judge Rudolph Randa rejected the settlement with Koss Corp., a headphone manufacturer accused of accounting fraud, saying that the settlement was too vague and that more facts were needed. The SEC has been…

Read More

Judge Upholds $327 Million Verdict Against Johnson & Johnson

A South Carolina circuit court judge upheld a $327 million jury verdict against Johnson & Johnson for its marketing of Risperdal, an anti-psychotic drug.  The case is one of several currently pending against the drug manufacturer alleging that it overstated the safety and effectiveness of Risperdal in marketing the drug to prescribing physicians.  The drug…

Read More

Aon Corp. to Pay $16.2M to Resolve Foreign Bribery Allegations with DOJ, SEC

Aon Corporation, an insurance brokerage firm, will pay over $16.2 million to settle allegations that it violated the Foreign Corrupt Practices Act by making improper payments to government officials in countries such as Vietnam, Costa Rica, Egypt, and the United Arab Emirates.  According to the government, the company’s subsidiaries paid over $3.6 million in bribes,…

Read More

Ranbaxy Laboratories to Pay $500 Million; Company Cuts Exec Pay

Ranbaxy Laboratories announced that it had made provision to pay $500 million in connection with a civil and criminal investigation by the Department of Justice relating to violations of the current Good Manufacturing Practices and falsification of records allowing the company to produce and sell medications that failed to meet FDA standards.  The drugs were…

Read More

Merck to Pay $24 Million to Massachusetts for Pricing Fraud

Merck became the thirteenth and final drug manufacturer to settle a pending suit brought by the state of Massachusetts alleging that it reported inflated prices in an effort to increase the reimbursements paid for its drugs by Medicaid and other health insurance plans.  The company has agreed to pay $24 million.  Merck lost its case…

Read More

SEC Chairman Discourages Attempt by Some in House to Undermine Whistleblower Program

SEC Chairman Mary Schapiro criticized a Congressional effort to make changes to the recently-effective SEC whistleblower program in a letter to Congressman Barney Frank (D-MA).  The bill, proposed by Congressman Michael Grimm (R-NY), waters down the program in response to complaints from corporations.  One key change would require whistleblowers to first report through their company’s…

Read More